History of the design of captopril and related inhibitors of angiotensin converting enzyme.
1991; Lippincott Williams & Wilkins; Volume: 17; Issue: 4 Linguagem: Inglês
10.1161/01.hyp.17.4.589
ISSN1524-4563
AutoresDavid W. Cushman, Miguel A. Ondetti,
Tópico(s)Computational Drug Discovery Methods
ResumoHomeHypertensionVol. 17, No. 4History of the design of captopril and related inhibitors of angiotensin converting enzyme. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBHistory of the design of captopril and related inhibitors of angiotensin converting enzyme. D W Cushman and M A Ondetti D W CushmanD W Cushman Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, N.J. and M A OndettiM A Ondetti Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, N.J. Originally published1 Apr 1991https://doi.org/10.1161/01.HYP.17.4.589Hypertension. 1991;17:589–592 eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited By Ribeiro E, Costa B, Vasques-Nóvoa F and Vale N (2023) In Vitro Drug Repurposing: Focus on Vasodilators, Cells, 10.3390/cells12040671, 12:4, (671) Cintra A, Costa T, Cezarette G, de Castro F, Pimenta D and Sampaio S (2023) Batroxin I: A Novel Bradykinin-Potentiating Peptide with Cytotoxic Activity Isolated from Bothrops atrox Snake Venom, International Journal of Peptide Research and Therapeutics, 10.1007/s10989-023-10493-7, 29:2 Vemula D, Jayasurya P, Sushmitha V, Kumar Y and Bhandari V (2023) CADD, AI and ML in drug discovery: A comprehensive review, European Journal of Pharmaceutical Sciences, 10.1016/j.ejps.2022.106324, 181, (106324), Online publication date: 1-Feb-2023. Borma L, Costa M, da Rocha H, Arieira J, Nascimento N, Jaramillo‐Giraldo C, Ambrosio G, Carneiro R, Venzon M, Neto A, van der Hoff R, Oliveira B, Rajão R and Nobre C (2022) Beyond Carbon: The Contributions of South American Tropical Humid and Subhumid Forests to Ecosystem Services, Reviews of Geophysics, 10.1029/2021RG000766, 60:4, Online publication date: 1-Dec-2022. Olivera S and Graham D (2022) Sex differences in preclinical models of hypertension, Journal of Human Hypertension, 10.1038/s41371-022-00770-1 Egan B, Scharf A, Pohl F and Kornfeld K (2022) Control of aging by the renin–angiotensin system: a review of C. elegans, Drosophila, and mammals, Frontiers in Pharmacology, 10.3389/fphar.2022.938650, 13 Seth M, Singh R, Hussain M, Pasha S and Fahim M (2022) Toxicity Study of 3-Thienylalanine- Ornithine-Proline (TOP) Using as Novel ACE Inhibitor, International Journal of Peptide Research and Therapeutics, 10.1007/s10989-022-10449-3, 28:5 ECKELMAN W, KUWERT T, CIARMIELLO A, RIONDATO M and MANSI L Changes over the years in radiopharmaceutical design, The Quarterly Journal of Nuclear Medicine and Molecular Imaging, 10.23736/S1824-4785.19.03216-3, 66:3 Han Y, Kamau P, Lai R and Luo L (2022) Bioactive Peptides and Proteins from Centipede Venoms, Molecules, 10.3390/molecules27144423, 27:14, (4423) Oliveira A, Viegas M, da Silva S, Soares A, Ramos M and Fernandes P (2022) The chemistry of snake venom and its medicinal potential, Nature Reviews Chemistry, 10.1038/s41570-022-00393-7, 6:7, (451-469) Coronado M, de Moraes F, Stuqui B, Calmon M, Eberle R, Rahal P and Arni R (2022) The Secreted Metabolome of Hela Cells under Effect of Crotamine, a Cell-Penetrating Peptide from a Rattlesnake Using NMR-Based Metabolomics Analyses, BioMed, 10.3390/biomed2020020, 2:2, (238-254) Lévy B and Mourad J (2021) Renin Angiotensin Blockers and Cardiac Protection: From Basics to Clinical Trials, American Journal of Hypertension, 10.1093/ajh/hpab108, 35:4, (293-302), Online publication date: 2-Apr-2022. Omidi S, Mehrpouya M, Oladnabi M, Azadmehr A, Kazemi-Lomedasht F and Yardehnavi N Evaluation of Venom as a Promising Tool for Drug Discovery: Focusing on Neurological Disorders, Venoms and Toxins, 10.2174/2666121701666211124151529, 2:1 Nystrom G, Fry L, Ellsworth S and Rokyta D (2022) Contrasting patterns of venom regeneration in a centipede (Scolopendra viridis) and a scorpion (Centruroides hentzi), Toxicon, 10.1016/j.toxicon.2022.02.022, 210, (132-140), Online publication date: 1-Apr-2022. Shu C, Zheng X, Wang Y, Xu Y, Zhang D and Deng S (2022) Captopril inhibits matrix metalloproteinase activity and improves dentin bonding durability, Clinical Oral Investigations, 10.1007/s00784-021-04303-x, 26:3, (3213-3225), Online publication date: 1-Mar-2022. Wilkerson R and Winters M (2022) Angiotensin-Converting Enzyme Inhibitor–Induced Angioedema, Emergency Medicine Clinics of North America, 10.1016/j.emc.2021.09.004, 40:1, (79-98), Online publication date: 1-Feb-2022. Fischer T and Riedl R (2022) Paracelsus' legacy in the faunal realm: Drugs deriving from animal toxins, Drug Discovery Today, 10.1016/j.drudis.2021.10.003, 27:2, (567-575), Online publication date: 1-Feb-2022. Cho C, Lu Y, Kim M, Jeon Y and Lee S (2022) Therapeutic Potential of Seaweed-Derived Bioactive Compounds for Cardiovascular Disease Treatment, Applied Sciences, 10.3390/app12031025, 12:3, (1025) Teixeira S, da Silva M, Gomes A, Moretti N, Lopes D, Ferro E and Rodrigues V (2022) Panacea within a Pandora's box: the antiparasitic effects of phospholipases A2 (PLA2s) from snake venoms, Trends in Parasitology, 10.1016/j.pt.2021.07.004, 38:1, (80-94), Online publication date: 1-Jan-2022. Kirsch D (2022) Drug Discovery in Big Pharma: Where "Birds" and "Fish" Collaborate to Find New Medicines Multidisciplinarity and Interdisciplinarity in Health, 10.1007/978-3-030-96814-4_13, (295-310), . Garsi J, Aguiar P and Hanessian S (2021) Design of Pseudodiproline Dimers as Mimetics of Pro-Pro Units: Stereocontrolled Synthesis, Configurational Relevance, and Structural Properties, The Journal of Organic Chemistry, 10.1021/acs.joc.1c02061, 86:23, (16834-16847), Online publication date: 3-Dec-2021. Coelho G, da Silva D, Beraldo-Neto E, Vigerelli H, de Oliveira L, Sciani J and Pimenta D (2021) Neglected Venomous Animals and Toxins: Underrated Biotechnological Tools in Drug Development, Toxins, 10.3390/toxins13120851, 13:12, (851) Das S, Amin S and Jha T (2021) Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies, European Journal of Medicinal Chemistry, 10.1016/j.ejmech.2021.113623, 223, (113623), Online publication date: 1-Nov-2021. Bhalla V, Blish C and South A (2020) A historical perspective on ACE2 in the COVID-19 era, Journal of Human Hypertension, 10.1038/s41371-020-00459-3, 35:10, (935-939), Online publication date: 1-Oct-2021. Kisaki C, Arcos S, Montoni F, da Silva Santos W, Calacina H, Lima I, Cajado-Carvalho D, Ferro E, Nishiyama-Jr M and Iwai L (2021) Bothrops Jararaca Snake Venom Modulates Key Cancer-Related Proteins in Breast Tumor Cell Lines, Toxins, 10.3390/toxins13080519, 13:8, (519) Wu Y and Meanwell N (2021) Geminal Diheteroatomic Motifs: Some Applications of Acetals, Ketals, and Their Sulfur and Nitrogen Homologues in Medicinal Chemistry and Drug Design, Journal of Medicinal Chemistry, 10.1021/acs.jmedchem.1c00790, 64:14, (9786-9874), Online publication date: 22-Jul-2021. Deshwal A, Phan P, Datta J, Kannan R and Thallapuranam S (2021) A Meta-Analysis of the Protein Components in Rattlesnake Venom, Toxins, 10.3390/toxins13060372, 13:6, (372) Badari J, Díaz-Roa A, Teixeira Rocha M, Mendonça R and Silva Junior P (2021) Patagonin-CRISP: Antimicrobial Activity and Source of Antimicrobial Molecules in Duvernoy's Gland Secretion (Philodryas patagoniensis Snake), Frontiers in Pharmacology, 10.3389/fphar.2020.586705, 11 Ahmed L, Abdou F, El Fiky A, Shaaban E and Ain-Shoka A (2020) Bradykinin-Potentiating Activity of a Gamma-Irradiated Bioactive Fraction Isolated from Scorpion (Leiurus quinquestriatus) Venom in Rats with Doxorubicin-Induced Acute Cardiotoxicity: Favorable Modulation of Oxidative Stress and Inflammatory, Fibrogenic and Apoptotic Pathways, Cardiovascular Toxicology, 10.1007/s12012-020-09602-5, 21:2, (127-141), Online publication date: 1-Feb-2021. Teixeira S, Borges B, Oliveira V, Carregosa L, Bastos L, Santos I, Jardim A, Melo F, Freitas L, Rodrigues V and Lopes D (2020) Insights into the antiviral activity of phospholipases A2 (PLA2s) from snake venoms, International Journal of Biological Macromolecules, 10.1016/j.ijbiomac.2020.07.178, 164, (616-625), Online publication date: 1-Dec-2020. Turner A, Kaas Q and Craik D (2020) Hormone-like conopeptides – new tools for pharmaceutical design, RSC Medicinal Chemistry, 10.1039/D0MD00173B, 11:11, (1235-1251) Herzig V, Cristofori-Armstrong B, Israel M, Nixon S, Vetter I and King G (2020) Animal toxins — Nature's evolutionary-refined toolkit for basic research and drug discovery, Biochemical Pharmacology, 10.1016/j.bcp.2020.114096, 181, (114096), Online publication date: 1-Nov-2020. McDermott A (2020) Venom back in vogue as a wellspring for drug candidates, Proceedings of the National Academy of Sciences, 10.1073/pnas.2004486117, 117:19, (10100-10104), Online publication date: 12-May-2020. KARA Ş and AKCAN M (2020) Disulfide-rich peptides in drug development, Hacettepe Journal of Biology and Chemistry, 10.15671/hjbc.658764 Bocian A and Hus K (2019) Antibacterial properties of snake venom components, Chemical Papers, 10.1007/s11696-019-00939-y, 74:2, (407-419), Online publication date: 1-Feb-2020. Silva D and Cunha Areias M (2019) Rutin as an Electrochemical Mediator in the Determination of Captopril using a Graphite Paste Electrode, Electroanalysis, 10.1002/elan.201900145, 32:2, (301-307), Online publication date: 1-Feb-2020. R. Oladipupo A (2020) Toxin to medicine and bioisosterism in drug development: a study of the discovery and development of ACE inhibitors from snake venom, Macedonian Pharmaceutical Bulletin, 10.33320/maced.pharm.bull.2020.66.02.003, 66:2, (15-33) Savitha M, Suvilesh K, Siddesha J, Milan Gowda M, Choudhury M, Velmurugan D, Umashankar M and Vishwanath B (2020) Combinatorial inhibition of Angiotensin converting enzyme, Neutral endopeptidase and Aminopeptidase N by N-methylated peptides alleviates blood pressure and fibrosis in rat model of dexamethasone-induced hypertension, Peptides, 10.1016/j.peptides.2019.170180, 123, (170180), Online publication date: 1-Jan-2020. Lazarovici P (2020) Snake- and Spider-Venom-Derived Toxins as Lead Compounds for Drug Development Snake and Spider Toxins, 10.1007/978-1-4939-9845-6_1, (3-26), . Pu L, Naderi M, Liu T, Wu H, Mukhopadhyay S and Brylinski M (2019) eToxPred: a machine learning-based approach to estimate the toxicity of drug candidates, BMC Pharmacology and Toxicology, 10.1186/s40360-018-0282-6, 20:1, Online publication date: 1-Dec-2019. Pedreira J, Franco L and Barreiro E Chemical Intuition in Drug Design and Discovery, Current Topics in Medicinal Chemistry, 10.2174/1568026619666190620144142, 19:19, (1679-1693) Yang X, Wang Y, Wu C and Ling E Animal Venom Peptides as a Treasure Trove for New Therapeutics Against Neurodegenerative Disorders, Current Medicinal Chemistry, 10.2174/0929867325666181031122438, 26:25, (4749-4774) Péterfi O, Boda F, Szabó Z, Ferencz E and Bába L (2019) Hypotensive Snake Venom Components—A Mini-Review, Molecules, 10.3390/molecules24152778, 24:15, (2778) Rivera-de-Torre E, Palacios-Ortega J, Gavilanes J, Martínez-del-Pozo Á and García-Linares S (2019) Pore-Forming Proteins from Cnidarians and Arachnids as Potential Biotechnological Tools, Toxins, 10.3390/toxins11060370, 11:6, (370) Clark G, Casewell N, Elliott C, Harvey A, Jamieson A, Strong P and Turner A (2019) Friends or Foes? Emerging Impacts of Biological Toxins, Trends in Biochemical Sciences, 10.1016/j.tibs.2018.12.004, 44:4, (365-379), Online publication date: 1-Apr-2019. Otvos R, Still K, Somsen G, Smit A and Kool J (2019) Drug Discovery on Natural Products: From Ion Channels to nAChRs, from Nature to Libraries, from Analytics to Assays, SLAS Discovery, 10.1177/2472555218822098, 24:3, (362-385), Online publication date: 1-Mar-2019. Zainal Abidin S, Lee Y, Othman I and Naidu R (2019) Malaysian Cobra Venom: A Potential Source of Anti-Cancer Therapeutic Agents, Toxins, 10.3390/toxins11020075, 11:2, (75) Dutt M, Dutertre S, Jin A, Lavergne V, Alewood P and Lewis R (2019) Venomics Reveals Venom Complexity of the Piscivorous Cone Snail, Conus tulipa, Marine Drugs, 10.3390/md17010071, 17:1, (71) Biswas B, Sundaram E, Jhansi S, Patel S, Khurana A and Manchanda R (2019) A review on animal-based homoeopathic drugs and their applications in biomedicine, Indian Journal of Research in Homoeopathy, 10.4103/ijrh.ijrh_20_19, 13:3, (159), . Aluko R (2018) Food protein-derived renin-inhibitory peptides: in vitro and in vivo properties , Journal of Food Biochemistry, 10.1111/jfbc.12648, 43:1, (e12648), Online publication date: 1-Jan-2019. Abroug F, Ouanes-Besbes L and Bouchoucha S (2018) Scorpion envenomation: from a neglected to a helpful disease?, Intensive Care Medicine, 10.1007/s00134-018-5226-5, 45:1, (72-74), Online publication date: 1-Jan-2019. Porter N, Shen S, Barinka C, Kozikowski A and Christianson D (2018) Molecular Basis for the Selective Inhibition of Histone Deacetylase 6 by a Mercaptoacetamide Inhibitor, ACS Medicinal Chemistry Letters, 10.1021/acsmedchemlett.8b00487, 9:12, (1301-1305), Online publication date: 13-Dec-2018. Eriksson A, Anand P, Gorson J, Grijuc C, Hadelia E, Stewart J, Holford M and Claridge-Chang A (2018) Using Drosophila behavioral assays to characterize terebrid venom-peptide bioactivity, Scientific Reports, 10.1038/s41598-018-33215-2, 8:1, Online publication date: 1-Dec-2018. Kany A, Sikandar A, Yahiaoui S, Haupenthal J, Walter I, Empting M, Köhnke J and Hartmann R (2018) Tackling Pseudomonas aeruginosa Virulence by a Hydroxamic Acid-Based LasB Inhibitor , ACS Chemical Biology, 10.1021/acschembio.8b00257, 13:9, (2449-2455), Online publication date: 21-Sep-2018. Li L, Huang J and Lin Y (2018) Snake Venoms in Cancer Therapy: Past, Present and Future, Toxins, 10.3390/toxins10090346, 10:9, (346) Kostis W, Shetty M, Chowdhury Y and Kostis J (2018) ACE Inhibitor-Induced Angioedema: a Review, Current Hypertension Reports, 10.1007/s11906-018-0859-x, 20:7, Online publication date: 1-Jul-2018. Bernstein K, Khan Z, Giani J, Cao D, Bernstein E and Shen X (2018) Angiotensin-converting enzyme in innate and adaptive immunity, Nature Reviews Nephrology, 10.1038/nrneph.2018.15, 14:5, (325-336), Online publication date: 1-May-2018. Pinheiro-Júnior E, Boldrini-França J, de Campos Araújo L, Santos-Filho N, Bendhack L, Cilli E and Arantes E (2018) LmrBPP9: A synthetic bradykinin-potentiating peptide from Lachesis muta rhombeata venom that inhibits the angiotensin-converting enzyme activity in vitro and reduces the blood pressure of hypertensive rats, Peptides, 10.1016/j.peptides.2018.01.015, 102, (1-7), Online publication date: 1-Apr-2018. Igić R (2018) Four decades of ocular renin-angiotensin and kallikrein-kinin systems (1977–2017), Experimental Eye Research, 10.1016/j.exer.2017.05.007, 166, (74-83), Online publication date: 1-Jan-2018. Sciani J and Pimenta D (2017) The modular nature of bradykinin-potentiating peptides isolated from snake venoms, Journal of Venomous Animals and Toxins including Tropical Diseases, 10.1186/s40409-017-0134-7, 23:1, Online publication date: 1-Dec-2017. Fucase T, Sciani J, Cavalcante I, Viala V, Chagas B, Pimenta D and Spencer P (2017) Isolation and biochemical characterization of bradykinin-potentiating peptides from Bitis gabonica rhinoceros, Journal of Venomous Animals and Toxins including Tropical Diseases, 10.1186/s40409-017-0124-9, 23:1, Online publication date: 1-Dec-2017. Still K, Nandlal R, Slagboom J, Somsen G, Casewell N and Kool J (2017) Multipurpose HTS Coagulation Analysis: Assay Development and Assessment of Coagulopathic Snake Venoms, Toxins, 10.3390/toxins9120382, 9:12, (382) Ma R, Mahadevappa R and Kwok H (2017) Venom-based peptide therapy: insights into anti-cancer mechanism, Oncotarget, 10.18632/oncotarget.21740, 8:59, (100908-100930), Online publication date: 21-Nov-2017. Pinter M and Jain R (2017) Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy, Science Translational Medicine, 10.1126/scitranslmed.aan5616, 9:410, Online publication date: 4-Oct-2017. Sestile C, Maraschin J, Rangel M, Santana R, Zangrossi H, Graeff F and Audi E (2017) B2-kinin receptors in the dorsal periaqueductal gray are implicated in the panicolytic-like effect of opiorphin, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 10.1016/j.pnpbp.2017.08.003, 79, (493-498), Online publication date: 1-Oct-2017. Mladic M, de Waal T, Burggraaff L, Slagboom J, Somsen G, Niessen W, Manjunatha Kini R and Kool J (2017) Rapid screening and identification of ACE inhibitors in snake venoms using at-line nanofractionation LC-MS, Analytical and Bioanalytical Chemistry, 10.1007/s00216-017-0531-3, 409:25, (5987-5997), Online publication date: 1-Oct-2017. Sestile C, Maraschin J, Gama V, Zangrossi H, Graeff F and Audi E (2017) Panicolytic-like action of bradykinin in the dorsal periaqueductal gray through μ-opioid and B2-kinin receptors, Neuropharmacology, 10.1016/j.neuropharm.2017.05.025, 123, (80-87), Online publication date: 1-Sep-2017. Johnson K, Shameer K, Glicksberg B, Readhead B, Sengupta P, Björkegren J, Kovacic J and Dudley J (2017) Enabling Precision Cardiology Through Multiscale Biology and Systems Medicine, JACC: Basic to Translational Science, 10.1016/j.jacbts.2016.11.010, 2:3, (311-327), Online publication date: 1-Jun-2017. Abu Hasan Z, Williams H, Ismail N, Othman H, Cozier G, Acharya K and Isaac R (2017) The toxicity of angiotensin converting enzyme inhibitors to larvae of the disease vectors Aedes aegypti and Anopheles gambiae, Scientific Reports, 10.1038/srep45409, 7:1 Kozlovac J and Hawley R (2016) Biological Toxins: Safety and Science Biological Safety, 10.1128/9781555819637.ch11, (247-268) Miller E (2017) Snakes and Hypertension, Anesthesiology, 10.1097/ALN.0000000000001441, 126:2, (321-324), Online publication date: 1-Feb-2017. Pai P and Mondal S (2017) Computational Approaches for Animal Toxins to Aid Drug Discovery Toxins and Drug Discovery, 10.1007/978-94-007-6452-1_20, (351-372), . Swerdel J, Rhoads G, Cheng J, Cosgrove N, Moreyra A, Kostis J, Kostis W, Cabrera J, Pantazopoulos J and Sargsyan D (2016) Ischemic Stroke Rate Increases in Young Adults: Evidence for a Generational Effect?, Journal of the American Heart Association, 5:12, Online publication date: 19-Dec-2016. Xu J, Pang J, Chen F, Li T and Zhao X (2016) Antihypertensive activities of the plasteins derived from casein hydrolysates in spontaneously hypertensive rats, CyTA - Journal of Food, 10.1080/19476337.2016.1217936, (1-5) Undheim E, Jenner R and King G (2016) Centipede venoms as a source of drug leads, Expert Opinion on Drug Discovery, 10.1080/17460441.2016.1235155, 11:12, (1139-1149), Online publication date: 1-Dec-2016. Gorson J and Holford M (2016) Small Packages, Big Returns: Uncovering the Venom Diversity of Small Invertebrate Conoidean Snails, Integrative and Comparative Biology, 10.1093/icb/icw063, 56:5, (962-972), Online publication date: 1-Nov-2016. Samy R, Sethi G and Lim L (2016) A brief update on potential molecular mechanisms underlying antimicrobial and wound-healing potency of snake venom molecules, Biochemical Pharmacology, 10.1016/j.bcp.2016.03.006, 115, (1-9), Online publication date: 1-Sep-2016. Debono J, Cochran C, Kuruppu S, Nouwens A, Rajapakse N, Kawasaki M, Wood K, Dobson J, Baumann K, Jouiaei M, Jackson T, Koludarov I, Low D, Ali S, Smith A, Barnes A and Fry B (2016) Canopy Venom: Proteomic Comparison among New World Arboreal Pit-Viper Venoms, Toxins, 10.3390/toxins8070210, 8:7, (210) Azim S, McDowell D, Cartagena A, Rodriguez R, Laughlin T and Ahmad Z (2016) Venom peptides cathelicidin and lycotoxin cause strong inhibition of Escherichia coli ATP synthase, International Journal of Biological Macromolecules, 10.1016/j.ijbiomac.2016.02.061, 87, (246-251), Online publication date: 1-Jun-2016. Verdes A, Anand P, Gorson J, Jannetti S, Kelly P, Leffler A, Simpson D, Ramrattan G and Holford M (2016) From Mollusks to Medicine: A Venomics Approach for the Discovery and Characterization of Therapeutics from Terebridae Peptide Toxins, Toxins, 10.3390/toxins8040117, 8:4, (117) Viala V, Hildebrand D, Fucase T, Sciani J, Prezotto-Neto J, Riedner M, Sanches L, Nishimura P, Oguiura N, Pimenta D, Schlüter H, Betzel C, Arni R and Spencer P (2015) Proteomic analysis of the rare Uracoan rattlesnake Crotalus vegrandis venom: Evidence of a broad arsenal of toxins, Toxicon, 10.1016/j.toxicon.2015.09.023, 107, (234-251), Online publication date: 1-Dec-2015. Zhan C, Li C, Wei X, Lu W and Lu W (2015) Toxins and derivatives in molecular pharmaceutics: Drug delivery and targeted therapy, Advanced Drug Delivery Reviews, 10.1016/j.addr.2015.04.025, 90, (101-118), Online publication date: 1-Aug-2015. Moore S, Bhat V, Flatt P, Gault V and McClean S (2015) Isolation and characterisation of insulin-releasing compounds from Crotalus adamanteus, Crotalus vegrandis and Bitis nasicornis venom, Toxicon, 10.1016/j.toxicon.2015.05.002, 101, (48-54), Online publication date: 1-Jul-2015. Puchalska P, Marina Alegre M and García López M (2014) Isolation and Characterization of Peptides with Antihypertensive Activity in Foodstuffs, Critical Reviews in Food Science and Nutrition, 10.1080/10408398.2012.664829, 55:4, (521-551), Online publication date: 21-Mar-2015. Nagai T, Nitta K, Kanasaki M, Koya D and Kanasaki K (2014) The biological significance of angiotensin-converting enzyme inhibition to combat kidney fibrosis, Clinical and Experimental Nephrology, 10.1007/s10157-014-1000-3, 19:1, (65-74), Online publication date: 1-Feb-2015. Ueki N, Takeda S, Koya D and Kanasaki K (2015) The Relevance of the Renin-Angiotensin System in the Development of Drugs to Combat Preeclampsia, International Journal of Endocrinology, 10.1155/2015/572713, 2015, (1-12), . Pai P and Mondal S (2015) Computational Approaches for Animal Toxins to Aid Drug Discovery Toxins and Drug Discovery, 10.1007/978-94-007-6726-3_20-1, (1-18), . Baici A (2015) Enzyme Inactivation with a Note on the Significance of Slow Modification Processes Kinetics of Enzyme-Modifier Interactions, 10.1007/978-3-7091-1402-5_9, (445-462), . Delcayre C, Fazal L, Ragot H, Prudhomme M, Azibani F and Samuel J (2015) The Renin-Angiotensin-Aldosterone System in Cardiovascular Diseases Introduction to Translational Cardiovascular Research, 10.1007/978-3-319-08798-6_4, (51-71), . Lopes D, Junior N, Costa P, Martins P, Santos C, Carvalho E, Carvalho M, Pimenta D, Cardi B, Fonteles M, Nascimento N and Carvalho K (2014) A new structurally atypical bradykinin-potentiating peptide isolated from Crotalus durissus cascavella venom (South American rattlesnake), Toxicon, 10.1016/j.toxicon.2014.07.011, 90, (36-44), Online publication date: 1-Nov-2014. Prashanth J, Brust A, Jin A, Alewood P, Dutertre S and Lewis R (2014) Cone snail venomics: from novel biology to novel therapeutics, Future Medicinal Chemistry, 10.4155/fmc.14.99, 6:15, (1659-1675), Online publication date: 1-Oct-2014. Anand P, Grigoryan A, Bhuiyan M, Ueberheide B, Russell V, Quinoñez J, Moy P, Chait B, Poget S, Holford M and Ho P (2014) Sample Limited Characterization of a Novel Disulfide-Rich Venom Peptide Toxin from Terebrid Marine Snail Terebra variegata, PLoS ONE, 10.1371/journal.pone.0094122, 9:4, (e94122) Ghassem M, Babji A, Said M, Mahmoodani F and Arihara K (2013) Angiotensin I-Converting Enzyme Inhibitory Peptides from Snakehead Fish Sarcoplasmic Protein Hydrolysate, Journal of Food Biochemistry, 10.1111/jfbc.12031, 38:2, (140-149), Online publication date: 1-Apr-2014. Patel A (2013) Clinical Relevance of Target Identity and Biology: Implications for Drug Discovery and Development, SLAS Discovery, 10.1177/1087057113505906, 18:10, (1164-1185), Online publication date: 1-Dec-2013. Casewell N, Wüster W, Vonk F, Harrison R and Fry B (2013) Complex cocktails: the evolutionary novelty of venoms, Trends in Ecology & Evolution, 10.1016/j.tree.2012.10.020, 28:4, (219-229), Online publication date: 1-Apr-2013. Harrison D and Luther J (2013) Vascular Pharmacology Vascular Medicine: A Companion to Braunwald's Heart Disease, 10.1016/B978-1-4377-2930-6.00006-9, (75-93), . Bingham J, Andrews E, Kiyabu S and Cabalteja C (2012) Drugs from Slugs. Part II – Conopeptide bioengineering, Chemico-Biological Interactions, 10.1016/j.cbi.2012.09.021, 200:2-3, (92-113), Online publication date: 1-Dec-2012. Polifka J (2012) Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence, Birth Defects Research Part A: Clinical and Molecular Teratology, 10.1002/bdra.23027, 94:8, (576-598), Online publication date: 1-Aug-2012. Koh C and Kini R (2012) From snake venom toxins to therapeutics – Cardiovascular examples, Toxicon, 10.1016/j.toxicon.2011.03.017, 59:4, (497-506), Online publication date: 1-Mar-2012. Kouchmeshky A, Jameie S, Amin G and Ziai S (2012) Investigation of Angiotensin-Convertings Enzyme Inhibitory Effects of Medicinal Plants Used in Traditional Persian Medicine for Treatment of Hypertension: Screening Study, Thrita, 10.5812/thrita.4264, 1:1, (13-23) Kanasaki M, Nagai T, Kitada M, Koya D and Kanasaki K (2011) Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors, Fibrogenesis & Tissue Repair, 10.1186/1755-1536-4-25, 4:1, Online publication date: 1-Dec-2011. King G (2011) Venoms as a platform for human drugs: translating toxins into therapeutics, Expert Opinion on Biological Therapy, 10.1517/14712598.2011.621940, 11:11, (1469-1484), Online publication date: 1-Nov-2011. Brown A and Captain B (2011) 50 Years of Thiazides: Should Thiazide Diuretics Be Considered Third-Line Hypertension Treatment?, American Journal of Therapeutics, 10.1097/MJT.0b013e3181e90863, 18:6, (e244-e254), Online publication date: 1-Nov-2011. Mansour M, Al-Ismaeel H, Al-Rikabi A and Al-Shabanah O (2011) Comparison of angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor blockade for the prevention of premalignant changes in the liver, Life Sciences, 10.1016/j.lfs.2011.06.002, 89:5-6, (188-194), Online publication date: 1-Aug-2011. Meyers K and Behar B (2011) Valsartan use in pediatric hypertension, Future Cardiology, 10.2217/fca.10.62, 7:2, (151-159), Online publication date: 1-Mar-2011. Popovici R, Seftel E, Mihai G, Popovici E and Voicu V (2011) Controlled Drug Delivery System Based on Ordered Mesoporous Silica Matrices of Captopril as Angiotensin-Converting Enzyme Inhibitor Drug, Journal of Pharmaceutical Sciences, 10.1002/jps.22308, 100:2, (704-714), Online publication date: 1-Feb-2011. Ferreira B, Santos D, Santos A, Rodrigues C, de Freitas C, Cabral L and Castro H (2011) Comparative Analysis of Viperidae Venoms Antibacterial Profile: a Short Communication for Proteomics , Evidence-Based Complementary and Alternative Medicine, 10.1093/ecam/nen052, 2011, (1-4), . Vetter I, Davis J, Rash L, Anangi R, Mobli M, Alewood P, Lewis R and King G (2010) Venomics: a new paradigm for natural products-based drug discovery, Amino Acids, 10.1007/s00726-010-0516-4, 40:1, (15-28), Online publication date: 1-Jan-2011. Adam M (2011) Multi-Level Complexities in Technological Development: Competing Strategies for Drug Discovery Science in the Context of Application, 10.1007/978-90-481-9051-5_5, (67-83), . Bdolah A (2010) Hypertensive and Hypotensive Snake Venom Components Toxins and Hemostasis, 10.1007/978-90-481-9295-3_37, (655-672), . Platten M, Youssef S, Hur E, Ho P, Han M, Lanz T, Phillips L, Goldstein M, Bhat R, Raine C, Sobel R and Steinman L (2009) Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity, Proceedings of the National Academy of Sciences, 10.1073/pnas.0903958106, 106:35, (14948-14953), Online publication date: 1-Sep-2009. Serrano G, Ritchie B, Hoffman D and Ferder L (2009) A new concept for an old system: The anti-inflammatory paradigm of the renin-angiotensin system, Medical Hypotheses, 10.1016/j.mehy.2008.11.036, 72:5, (584-588), Online publication date: 1-May-2009. Ventura H (2009) History of Heart Failure, Congestive Heart Failure, 10.1111/j.1751-7133.2008.00034.x, 15:1, (49-49), Online publication date: 1-Jan-2009. Ventura H (2008) History of Heart Failure, Congestive Heart Failure, 10.1111/j.1751-7133.2008.00015.x, 14:6, (329-329), Online publication date: 1-Nov-2008. Ventura H (2008) Historical Vignettes in Heart Failure, Congestive Heart Failure, 10.1111/j.1751-7133.2008.00007.x, 14:5, (288-288) Ventura H (2008) Historical Vignettes in Heart Failure, Congestive Heart Failure, 10.1111/j.1751-7133.2008.07985.x, 14:4, (218-218), Online publication date: 1-Jul-2008. Menin L, Perchuć A, Favreau P, Perret F, Michalet S, Schöni R, Wilmer
Referência(s)